Use of standard markers and incorporation of molecular markers into breast cancer therapy
出版年份 2010 全文链接
标题
Use of standard markers and incorporation of molecular markers into breast cancer therapy
作者
关键词
-
出版物
CANCER
Volume 117, Issue 8, Pages 1575-1582
出版商
Wiley
发表日期
2010-11-30
DOI
10.1002/cncr.25660
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer
- (2013) Luigi Marchionni et al. ANNALS OF INTERNAL MEDICINE
- Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers
- (2010) Catherine M. Kelly et al. CANCER
- Prognostic Value of a Combined ER, PgR, Ki67, HER2 Immunohistochemical (IHC4) Score and Comparison with the GHI Recurrence Score – Results from TransATAC.:
- (2010) J. Cuzick et al. CANCER RESEARCH
- Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
- (2010) G. Viale et al. CANCER RESEARCH
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
- (2009) Thomas Karn et al. BREAST CANCER RESEARCH AND TREATMENT
- Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
- (2009) J. A. Sparano et al. CLINICAL CANCER RESEARCH
- Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial
- (2009) S. Mook et al. EUROPEAN JOURNAL OF CANCER
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
- (2008) A. Rody et al. BREAST CANCER RESEARCH AND TREATMENT
- Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials
- (2008) Brian R. Leyland-Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Proficiency testing of immunohistochemical biomarker assays in breast cancer
- (2008) Reinhard von Wasielewski et al. VIRCHOWS ARCHIV
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now